Therapeutic Efficacy of Nanodrug Delivery Compared With Current Nonsurgical Treatments for Patients With Cutaneous Melanoma: A Systematic Review. [PDF]
Hussain Z +4 more
europepmc +1 more source
Comprehensive quantum chemical analysis, vibrational spectroscopy, molecular docking, ADMET, and in vitro validation studies of hydroxychloroquine-MRGPRX2 complex in IDH-wildtype glioblastoma. [PDF]
Demirag AD +4 more
europepmc +1 more source
Efficacy and safety of hypofractionated radiotherapy combined with temozolomide in patients with newly diagnosed glioblastoma with poor prognosis: a single-center retrospective analysis. [PDF]
Fu F +8 more
europepmc +1 more source
Glioblastoma, <i>IDH-</i>wildtype, with a novel <i>MEF2D-NTRK1</i> gene fusion: a case report. [PDF]
Dewey A +5 more
europepmc +1 more source
Temozolomide in aggressive and metastatic pituitary tumors: a Brazilian multicenter real-world cohort study. [PDF]
de Magalhães IPA +22 more
europepmc +1 more source
Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma. [PDF]
Urbonas V, Dulskas A.
europepmc +1 more source
Retraction Note: Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway. [PDF]
Xu P, Wang H, Pan H, Chen J, Deng C.
europepmc +1 more source
Targeted and systemic therapies for recurrent adult ependymomas: real-world outcomes from a single institution and concise literature review. [PDF]
Maccari M +14 more
europepmc +1 more source
High-grade astrocytoma with piloid features: a case report of comprehensive management. [PDF]
He Q, Wang F, Cao H, Li Z, Sun M.
europepmc +1 more source

